[1]
Shahabi Raberi, V. et al. 2022. Drug Resistance and Cardiovascular Safety of Second-Generation Anti-Androgens in Patients with Advanced Prostate Cancer. Galen Medical Journal. 11, (Dec. 2022), e2727. DOI:https://doi.org/10.31661/gmj.v11i.2727.